Viewing Study NCT02745860


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-06-08 @ 7:35 PM
Study NCT ID: NCT02745860
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2016-04-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Two Dose Strengths of Selexipag in Healthy Adults
Sponsor: Actelion
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module